Epidemiology of Non-Alcoholic Fatty Liver Disease
The DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20–30%. About 2–3% of the general population is estimated to have non-alcoholic steatohepatitis (NASH), which may progress to liver cirrhosis and hepatocarcinoma. As a rule, the prevalence of NAFLD is higher in males and increases with increasing age, and it is influenced by the diagnostic method and the characteristics of the population, especially lifestyle habits. Population-based studies provide better estimates of the prevalence of NAFLD as compared to autoptic and clinical studies, but few such studies have been performed to date. The diagnosis of NAFLD in population studies is usually obtained by ultrasonography, which is known to underestimate the prevalence of fatty liver. The Dallas Heart Study and the Dionysos Study reported that 30% of the adults in the USA and 25% in Italy have NAFLD. In these studies, 79% and 55% of patients with NAFLD had normal aminotransferase levels, showing that liver enzymes are not surrogate markers of NAFLD in the general population. Noninvasive markers such as the fatty liver index obtained from the Dionysos Study may be useful to screen for NAFLD in the general population. The most important risk factors for NAFLD are male gender, age, obesity, insulin resistance and the cardiometabolic alterations that define the metabolic syndrome. The prevalence of NAFLD is 80–90% in obese adults, 30–50% in patients with diabetes and up to 90% in patients with hyperlipidemia. The prevalence of NAFLD among children is 3–10%, rising up to 40–70% among obese children. Moreover, pediatric NAFLD increased from about 3% a decade ago to 5% today, with a male-to-female ratio of 2:1. The incidence and natural history of NAFLD are still not well defined, but it is recognized that the majority of individuals with NAFLD do not develop NASH. The incidence of NAFLD is probably increasing in Western countries, strictly linked to lifestyle habits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of NAFLD among normal-weight children is 3–10%, rising up to 40–70% among obese children”
From Lack of Exercise Is a Major Cause of Chronic Diseases (2012) · cites this paper as [33]
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · cited 1×
“In the literature, many competing definitions of the MS are available. The definition recently put forth by the International Federation for the Study of Diabetes (IDF) [”
BackgroundNonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , , , , , , , , , , , ,”
MethodNonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · cited 1×
“] and 15p in Asian countries [ , , , , , , , , , ,”
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042 · cited 1×
“We suggest to expand the number of prospective cohort studies in the general population, even if they are more expensive and difficult to handle, because they give more reliable results about the burden of disease attributable to NAFLD. The most simple, noninvasive and practical method for diagnosing FL in population…”
BackgroundSelf-citationLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679 · cited 1×
“Population and clinical studies have increasingly shown that most cases of NAFLD are associated with the metabolic syndrome (MS), so that NAFLD is presently considered the hepatic manifestation of MS [”
BackgroundNonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154 · cited 1×
“Definition and Classification of Non-Alcoholic Fatty Liver DiseaseNon-alcoholic fatty liver disease (NAFLD) is operationally defined as fatty liver (FL), i.e. an accumulation of lipids inside the hepatocytes exceeding 5p of the weight of the liver, without hepatitis B virus or hepatitis C virus infection and in the ab…”
BackgroundIndependent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610 · cited 1×
“A recent study showed that 27p of US adults have raised levels of liver enzymes and that 79p of these values cannot be explained by the most common causes of liver disease [ , , , , , , , ,”
BackgroundAssociation of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568 · cited 1×
“While steatosis is usually associated with a benign prognosis, steatohepatitis and fibrosis may progress to cirrhosis and possibly hepatocarcinoma.During the last decade, the number of studies on NAFLD has grown exponentially, and new concepts have been acquired by the scientific community. We now know that NAFLD is o…”
BackgroundPowell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Dixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360 · cited 1×
“A recent study showed that 27p of US adults have raised levels of liver enzymes and that 79p of these values cannot be explained by the most common causes of liver disease [ , , , , , , , , ,”
BackgroundDorland??s Illustrated Medical Dictionary
AREY, L. B., BURROWS, W., GREENHILL, J. P., & HEWITT, R. M. (1957) · the american journal of the medical sciences · doi:10.1097/00000441-195712000-00043 · Cited by 1,347
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Self-citationBedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , , , , ,”
MethodSelf-citationMofrad, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,201 · cited 1×
“A recent study showed that 27p of US adults have raised levels of liver enzymes and that 79p of these values cannot be explained by the most common causes of liver disease [ , , , ,”
BackgroundFatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , ,”
MethodNonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
Non‐alcoholic fatty liver disease
ANGULO, P., & LINDOR, K. D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s1.10.x · Cited by 835
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
Falck-Ytter, Y., Younossi, Z. M., Marchesini, G., & McCullough, A. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12926 · Cited by 673 · cited 1×
“While steatosis is usually associated with a benign prognosis, steatohepatitis and fibrosis may progress to cirrhosis and possibly hepatocarcinoma.During the last decade, the number of studies on NAFLD has grown exponentially, and new concepts have been acquired by the scientific community. We now know that NAFLD is o…”
BackgroundIncreased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.018 · Cited by 638 · cited 1×
“requires the presence of central obesity (waist circumference >94 cm for European men and >80 cm for European women) and at least two of the following factors: (1) triglycerides >1.70 mmol/l or specific treatment, (2) HDL-cholesterol 130 mm Hg or diastolic >85 mm Hg or specific treatment, and/or (4) fasting glucose >5…”
InfluentialThe clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
McCullough, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.004 · Cited by 580 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , ,”
MethodNonalcoholic steatohepatitis: A study of 49 patients
Lee, R. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90249-9 · Cited by 550 · cited 1×
“] and 15p in Asian countries [ , , , , , , , , , , , ,”
Caldwell, S. H., & Crespo, D. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.013 · Cited by 501
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
Luyckx, F., Desaive, C., Thiry, A., Dewé, W., Scheen, A., Gielen, J., & Lefèbvre, P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800571 · Cited by 489 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , ,”
MethodAlcohollike liver disease in nonalcoholics
Diehl, A. M., Goodman, Z., & Ishak, K. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90183-7 · Cited by 483
Epidemiology and Natural History of NAFLD and NASH
Ong, J. P., & Younossi, Z. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.009 · Cited by 457 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , , , , , , , , , , , , , ,”
MethodNonalcoholic Fatty Liver Disease: An Underrecognized Cause of Cryptogenic Cirrhosis
Clark, J. M., & Diehl, A. M. (2003) · JAMA · doi:10.1001/jama.289.22.3000 · Cited by 428 · cited 1×
“]: (1) recognized etiological agent(s), (2) identifiable group of signs and symptoms, and (3) consistent anatomic alterations. NAFL(D) has no recognized etiological agents and does not have an identifiable group of signs and symptoms (one may add that its histopathological alterations are not pathognomonic). We propos…”
BackgroundSchindhelm, R. K., Dekker, J. M., Nijpels, G., Bouter, L. M., Stehouwer, C. D. A., Heine, R. J., & Diamant, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.006 · Cited by 420 · cited 1×
“We obtained the same result in our Dionysos cohort after a median follow-up of 8.5 years (table 3 ). In some, but not all, studies, a diagnosis of NAFLD was associated with a shorter survival than expected for the general population, with the increased mortality due mostly to cardiovascular disease. An association bet…”
ResultInfluentialNonalcoholic Steatohepatitis in Children
Rashid, M., & Roberts, E. A. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2000.tb02653.x · Cited by 411
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
Alkhouri, N., Dixon, L. J., & Feldstein, A. E. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.32 · Cited by 399 · cited 1×
“In support of this idea, subjects with genetic alterations of the insulin receptor and others with various kinds of lipodystrophy often have NAFLD [ ,”
BackgroundGastaldelli, A., Kozakova, M., Hφjlund, K., Flyvbjerg, A., Favuzzi, A., Mitrakou, A., & Balkau, B. (2009) · Hepatology · doi:10.1002/hep.22845 · Cited by 377 · cited 1×
“We suggest to expand the number of prospective cohort studies in the general population, even if they are more expensive and difficult to handle, because they give more reliable results about the burden of disease attributable to NAFLD. The most simple, noninvasive and practical method for diagnosing FL in population…”
BackgroundPrevalence of fatty liver in a general population of Okinawa, Japan.
NOMURA, H., KASHIWAGI, S., HAYASHI, J., KAJIYAMA, W., TANI, S., & GOTO, M. (1988) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.27.142 · Cited by 355
Daniel, S. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00507-9 · Cited by 354 · cited 1×
“A recent study showed that 27p of US adults have raised levels of liver enzymes and that 79p of these values cannot be explained by the most common causes of liver disease [ , , , , ,”
BackgroundAminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
Goessling, W., Massaro, J. M., Vasan, R. S., D'Agostino, R. B., Ellison, R. C., & Fox, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.018 · Cited by 330 · cited 1×
“We obtained the same result in our Dionysos cohort after a median follow-up of 8.5 years (table 3 ). In some, but not all, studies, a diagnosis of NAFLD was associated with a shorter survival than expected for the general population, with the increased mortality due mostly to cardiovascular disease. An association bet…”
ResultInfluentialMarcos, A., Fisher, R. A., Ham, J. M., Shiffman, M. L., Sanyal, A. J., Luketic, V. A. C., Sterling, R. K., Fulcher, A. S., & Posner, M. P. (2000) · Transplantation · doi:10.1097/00007890-200004150-00028 · Cited by 324
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
Bellentani, S., & Marino, M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31820-4 · Cited by 322
Self-citationLiver pathology in morbidly obese patients with and without diabetes.
Silverman, J. F., O’Brien, K. F., Long, S., Leggett-Frazier, N., Khazanie, P. G., Pories, W. J., Norris, H. T., & F., J. (1990) · PubMed · Cited by 301
Non-Alcoholic Fatty Liver Disease in Older People
Frith, J., Day, C. P., Henderson, E., Burt, A. D., & Newton, J. L. (2009) · Gerontology · doi:10.1159/000235677 · Cited by 282
Fatty liver in non‐alcoholic non‐overweight Japanese adults: Incidence and clinical characteristics
Omagari, K., Kadokawa, Y., Masuda, J., Egawa, I., Sawa, T., Hazama, H., Ohba, K., Isomoto, H., Mizuta, Y., Hayashida, K., et al. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02846.x · Cited by 275 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , , , , , , , ,”
MethodHultcrantz, R., Glaumann, H., Lindberg, G., & H:son Nilsson, L. (1986) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528609034632 · Cited by 261 · cited 1×
“A recent study showed that 27p of US adults have raised levels of liver enzymes and that 79p of these values cannot be explained by the most common causes of liver disease [ , , , , , , ,”
BackgroundCryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease
Ong, J., Younossi, Z. M., Reddy, V., Price, L. L., Gramlich, T., Mayes, J., & Boparai, N. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.24644 · Cited by 258
Fujita, K., Nozaki, Y., Wada, K., Yoneda, M., Fujimoto, Y., Fujitake, M., Endo, H., Takahashi, H., Inamori, M., Kobayashi, N., et al. (2009) · Hepatology · doi:10.1002/hep.23094 · Cited by 244 · cited 1×
“In support of this idea, subjects with genetic alterations of the insulin receptor and others with various kinds of lipodystrophy often have NAFLD [ , ,”
BackgroundLiver Histology in a ‘Normal’ Population—Examinations of 503 Consecutive Fatal Traffic Casualties
Hilden, M., Christoffersen, P., Juhl, E., & Dalgaard, J. B. (1977) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527709181339 · Cited by 243 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [”
Method&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200111000-00029 · Cited by 243
Fargion, S. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02615-6 · Cited by 233 · cited 1×
“A recent study showed that 27p of US adults have raised levels of liver enzymes and that 79p of these values cannot be explained by the most common causes of liver disease [ , ,”
BackgroundIncidence and natural course of fatty liver in the general population: The Dionysos study
Bedogni, G., Miglioli, L., Masutti, F., Castiglione, A., Crocè, L. S., Tiribelli, C., & Bellentani, S. (2007) · Hepatology · doi:10.1002/hep.21827 · Cited by 226 · cited 1×
“Even if it is not yet clear whether NAFLD has a causative role in cardiovascular disease, it surely is associated with its development, and as a result, hepatologists should start to evaluate the cardiovascular risk of their patients with NAFLD. Incidence Very few data are available on the incidence of NAFLD in the ge…”
BackgroundSelf-citationGuzman, G., Brunt, E. M., Petrovic, L. M., Chejfec, G., Layden, T. J., & Cotler, S. J. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/132.11.1761 · Cited by 212
Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies
Clark, J. M., & Diehl, A. M. (2003) · Gastroenterology · doi:10.1053/gast.2003.50032 · Cited by 167 · cited 1×
“A recent study showed that 27p of US adults have raised levels of liver enzymes and that 79p of these values cannot be explained by the most common causes of liver disease [”
BackgroundThe epidemiology of fatty liver
Bellentani, S., Bedogni, G., Miglioli, L., & Tiribelli, C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00002 · Cited by 165 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , , , ,”
MethodSelf-citationStatins and hepatic steatosis: Perspectives from the Dallas Heart Study
Browning, J. D. (2006) · Hepatology · doi:10.1002/hep.21248 · Cited by 162
El-Hassan, A. Y., Ibrahim, E. M., Al-Mulhim, F. A., Nabhan, A. A., & Chammas, M. Y. (1992) · British Journal of Radiology · doi:10.1259/0007-1285-65-777-774 · Cited by 149 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , , , , , , , , , , ,”
MethodBerasain, C., Betés, M., Panizo, A., Ruiz, J., Herrero, J. I., Civeira, M.-P., & Prieto, J. (2000) · Gut · doi:10.1136/gut.47.3.429 · Cited by 131 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , ,”
MethodOng, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/s0168-8278(08)60008-2 · Cited by 119
The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern.
Lonardo, A., Bellini, M., Tartoni, P., & Tondelli, E. (1997) · PubMed · Cited by 118
Review article: hepatic steatosis and insulin resistance
Lonardo, A., Lombardini, S., RICCHI, M., Scaglioni, F., & Loria, P. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02600.x · Cited by 110 · cited 1×
“While steatosis is usually associated with a benign prognosis, steatohepatitis and fibrosis may progress to cirrhosis and possibly hepatocarcinoma.During the last decade, the number of studies on NAFLD has grown exponentially, and new concepts have been acquired by the scientific community. We now know that NAFLD is o…”
BackgroundSelf-citationIkai, E., Ishizaki, M., Suzuki, Y., Ishida, M., Noborizaka, Y., & Yamada, Y. (1995) · PubMed · Cited by 104
The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation
Hwang, S., Lee, S., Jang, S.-J., Cho, S.-H., Kim, K., Ahn, C., Moon, D., & Ha, T. (2004) · Liver Transplantation · doi:10.1002/lt.20172 · Cited by 96 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , ,”
MethodNonomura, A., Mizukam, Y., Unoura, M., Kobayashi, K., Takeda, Y., & Takeda, R. (1992) · Gastroenterologia Japonica · doi:10.1007/bf02777789 · Cited by 95
Fatty liver: How frequent is it and why?
Bedogni, G., & Bellentani, S. (2004) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32110-6 · Cited by 90
Self-citationShould Nonalcoholic Fatty Liver Disease Be Renamed?
Loria, P., Lonardo, A., & Carulli, N. (2005) · Digestive Diseases · doi:10.1159/000084728 · Cited by 85
Liver Damage in Obese Patients
Gaudio, A. D., Boschi, L., Gaudio, G.-A. D., Mastrangelo, L., & Munari, D. (2002) · Obesity Surgery · doi:10.1381/096089202320995592 · Cited by 79 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , ,”
MethodGround, K. E. (1982) · PubMed · Cited by 70
Non-alcoholic fatty liver disease
Bjornsson, E. S., & Angulo, P. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701514529 · Cited by 68
Radu, C., Grigorescu, M. D., Crișan, D., Lupșor‐Platon, M., Constantin, D., & Dina, L. A. (2008) · PubMed · Cited by 68
Patt, C. H., Yoo, H. Y., Dibadj, K., Flynn, J. A., & Thuluvath, P. J. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1022809430756 · Cited by 63 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , , , , , , , , , , , , ,”
MethodLiver and biliary ultrasonography in diabetic and non-diabetic obese women.
Lm, A., Da, D. O., & Ds, N. (1998) · PubMed · Cited by 45
Nonalcoholic steatohepatitis and hepatocellular carcinoma in galectin‐3 knockout mice
Nakanishi, Y., Tsuneyama, K., Nomoto, K., Fujimoto, M., Salunga, T. L., Nakajima, T., Miwa, S., Murai, Y., Hayashi, S., Kato, I., et al. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00395.x · Cited by 40 · cited 1×
“]: (1) recognized etiological agent(s), (2) identifiable group of signs and symptoms, and (3) consistent anatomic alterations. NAFL(D) has no recognized etiological agents and does not have an identifiable group of signs and symptoms (one may add that its histopathological alterations are not pathognomonic). We propos…”
BackgroundCurcumin adds spice to the debate: lipid metabolism in liver disease
Graham, A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00335.x · Cited by 28 · cited 1×
“In support of this idea, subjects with genetic alterations of the insulin receptor and others with various kinds of lipodystrophy often have NAFLD [”
BackgroundTargher, G., Bertolini, L., Tessari, R., Zenari, L., & Arcaro, G. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01940.x · Cited by 19 · cited 1×
“We obtained the same result in our Dionysos cohort after a median follow-up of 8.5 years (table 3 ). In some, but not all, studies, a diagnosis of NAFLD was associated with a shorter survival than expected for the general population, with the increased mortality due mostly to cardiovascular disease. An association bet…”
ResultInfluentialEffect of weight changes on serum transaminase activities in obese children
Tazawa, Y., NOGUCHI, H., Nishinomiya, F., & Takada, G. (1997) · Pediatrics International · doi:10.1111/j.1442-200x.1997.tb03583.x · Cited by 19
Contribution of Bariatric Surgery to the Comprehension of Morbid Obesity
Marceau, P. (2005) · Obesity Surgery · doi:10.1381/0960892052993620 · Cited by 16 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , ,”
MethodNAFLD and Cardiovascular Risk: Direct Evidence for the Tale of Two Ages
Lonardo, A., & Loria, P. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.233 · Cited by 11 · cited 1×
“While steatosis is usually associated with a benign prognosis, steatohepatitis and fibrosis may progress to cirrhosis and possibly hepatocarcinoma.During the last decade, the number of studies on NAFLD has grown exponentially, and new concepts have been acquired by the scientific community. We now know that NAFLD is o…”
BackgroundPatient selection for treatment of obesity
Kral, J. G. (2005) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2005.02.005 · Cited by 9 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , ,”
MethodKawai, N., Tsugaya, M., Sasaki, S., Sakagami, H., & Kohri, K. (1997) · The Japanese Journal of Urology · doi:10.5980/jpnjurol1989.88.997 · Cited by 4
Research works printed but not linked: 7
- 10.1097%2f00005176-200001000-00017 · doi:10.1097/00005176-200001000-00017 · Paper page
- 10.1016%2fs1590-8658%2802%2980194-3 · DOI
- 10.1111%2fj.1572-0241.2001.04052.x · doi:10.1111/j.1572-0241.2001.04052.x · Paper page
- 10.1016%2fs0168-8278%2801%2900094-0 · DOI · Paper page
- 10.1111%2fj.1572-0241.1999.01451.x · doi:10.1111/j.1572-0241.1999.01451.x · Paper page
- 10.3109%2f00365527709181339 · DOI · Paper page
- 10.1053%2fgast.2001.25540 · DOI · Paper page
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
“In people with NAFLD but without T2D, ameliorating NAFLD decreases T2D risk even after controlling for changes in weight (933).”
BackgroundInfluentialLack of Exercise Is a Major Cause of Chronic Diseases
Booth, F. W., Roberts, C. K., & Laye, M. J. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110025 · Cited by 2,575
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Cotter, T. G., & Rinella, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.052 · Cited by 1,198
Metadata
- Authors
- Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G.
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 28
- Issue
- 1
- Pages
- 155-161
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2036047239
- Cited by
- 1,026
- References
- 77
- Citations by year
- 2026: 7 · 2025: 19 · 2024: 31 · 2023: 51 · 2022: 72 · 2021: 71 · 2020: 78 · 2019: 85 · 2018: 96 · 2017: 97 · 2016: 89 · 2015: 84 · 2014: 71 · 2013: 81 · 2012: 48
- FWCI
- 40.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Digestive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- non-alcoholic fatty liver disease, prevalence, nonalcoholic steatohepatitis, liver cirrhosis, hepatocellular carcinoma, risk factors, obesity, insulin resistance, metabolic syndrome, fatty liver index, NAFLD screening, pediatric NAFLD, incidence, lifestyle, transaminases
- MeSH terms
- Adult, Aged, Fatty Liver, Female, Humans, Italy, Male, Middle Aged, Risk Factors, United States, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.